7
USU Home A-Z index calendars MyUSU contact people/web search
 

Department of Animal, Dairy and Veterinary Sciences
 

mugshot



John D. Morrey, PhD
 Research Professor


Utah State University
ADVS Department
4815 Old Main Hill
Logan UT 84322-4700

phone (435)797-2622
fax (435)797-2118
email jmorrey at cc.usu.edu

 

  
PUBLICATIONS
  1. Sidwell, R. W., D. L. Barnard, C. W. Day, D. F. Smee, K. W. Bailey, M. H. Wang, Morrey, J. D., and Y. Furuta. (Accepted). Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice. Antimicrob Agents Chemother.


  2. Julander, J. G., V. Siddharthan, L. M. Blatt, K. Schafer, R. W. Sidwell, and Morrey, J. D. (Accepted). Effect of exogenous interferon and an interferon inducer on western equine encephalitis virus disease in a hamster model. Virology.


  3. Samuel, M. A., Morrey, J. D., J. W. Olney, and M. S. Diamond. (Accepted). Caspase-3 dependent cell death of neurons contributes to the pathogenesis of West Nile virus encephalitis. J Virol.


  4. Olsen, A. L., J. D. Morrey, D. F. Smee, and R. W. Sidwell. (Accepted). Correlation between breakdown of the blood-brain-barrier and disease outcome of viral encephalitis in mice. Antiviral Res.


  5. Torrence, P. F., N. Gupta, C. Whitney, and Morrey, J. D., 2006. Inhibition of West Nile virus replication by synthetic oligonucleotides. Antiviral Res. 70:60-5. blood-brain-barrier and disease outcome of viral encephalitis in mice." Antiviral Res


  6. Stuyver, L. J., T. R. McBrayer, P. M. Tharnish, J. Clark, L. Hollecker, S. Lostia, T. Nachman, J. Grier, M. A. Bennett, M.-Y. Xie, R. F. Schinazi, Morrey, J. D., J. G. Julander, P. A. Furman, and M. J. Otto, 2006. Inhibition of hepatitis C replicon RNA synthesis by b-d-2'-deoxy-2'-fluoro-2'-C-methylcytidine: a specific inhibitor of hepatitis C virus replication. Antiviral Chemistry and Chemotherapy 17:79-87.


  7. Morrey, J. D., V. Siddharthan, A. L. Olsen, G. Y. Roper, H. C. Wang, T. J. Baldwin, S. Koenig, S. Johnson, J. L. Nordstrom, and M. S. Diamond, 2006. Humanized monoclonal antibody against West Nile virus E protein administered after neuronal infection protects against lethal encephalitis in hamsters. Journal of Infectious Disease 194:1300-08.


  8. Kocisko, D. A., W. S. Caughey, R. E. Race, G. Roper, B. Caughey, and Morrey, J. D., 2006. A porphyrin increases survival time of mice after intracerebral prion infection. Antimicrob Agents Chemother 50:759-61.


  9. Kocisko, D. A., B. Caughey, Morrey, J. D., and R. E. Race, 2006. Enhanced antiscrapie effect using combination drug treatment. Antimicrob Agents Chemother 39:646-9.


  10. Julander, J. G., Q. A. Winger, L. F. Rickords, P. Y. Shi, M. Tilgner, H. M. Gavin, R. W. Sidwell, and Morrey, J. D., 2006. West Nile virus infection of the placenta. Virology 347:175-82.


  11. Caughey, B., W. S. Caughey, D. A. Kocisko, K. S. Lee, J. R. Silveira, and Morrey, J. D., 2006. Prions and transmissible spongiform encephalopathy (TSE) chemotherapeutics: A common mechanism for anti-TSE compounds? Acc Chem Res, 39:646-53.


  12. Ojwang, J. O., S. Ali, D. F. Smee, Morrey, J. D., C. D. Shimasaki, and R. W. Sidwell, 2005. Broad-spectrum inhibitor of viruses in the Flaviviridae family. Antiviral Res 68:49-55.


  13. Radhakrishnan, P. I., S. P., G. Z., Morrey, J. D., and B. E. Korba, 2005. Nucleotide analogs as novel anti-hepatitis B virus agents. Current Opinions in Pharmacology 5:520-528.


  14. Julander, J. G., Q. A. Winger, A. L. Olsen, C. W. Day, R. W. Sidwell, and Morrey, J. D., 2005. Treatment of West Nile virus-infected mice with reactive immumoglobulin reduces fetal titers and increases dam survival. Antiviral Res. 65:79-85.


  15. Day, C. W., D. F. Smee, J. G. Julander, V. F. Yamshchikov, R. W. Sidwell, and Morrey, J. D., 2005. Error-prone replication of West Nile virus caused by ribavirin. Antiviral Res 67:38-45.


  16. Barnard D.L., V.D. Hubbard, J. Burton, D.F. Smee, and Morrey, J. D., 2004. Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and b-D-N4-hydroxycytidine. Antivir. Chem. Chemother. 15: 15-22.


  17. Julander, J.G., Q.A. Winger, A.L. Olsen, C.W. Day, R.W. Sidwell, and Morrey, J. D., 2005. Treatment of West Nile virus-infected mice with reactive immumoglobulin reduces fetal titers and increases dam survival. Antiviral Res. 65:79-85


  18. Sidwell, R.W., K.W. Bailey, Morrey, J. D., M.H. Wong, T.J. Baldwin, and D.F. Smee, 2003. Inhibition of influenza virus infections in immunosuppressed mice with orally administered Peramivir (BCX-1812). Antiviral Research 60:17-25.


  19. Kocisko, D.A., Morrey, J. D., R.E. Race, J. Chen, and B. Caughey, 2004. Evaluation of new cell culture inhibitors of protease-resistant prion protein against scrapie infection in mice. J Gen Virol. 85(Pt 8):2479-83.


  20. Morrey, J.D., C.W. Day, J.G. Julander, A.L. Olsen, R.W. Sidwell, C.D. Cheney, and L.M. Blatt, 2004. Modeling hamsters for evaluating West Nile virus therapies. Antiviral Research. 63(1):41-50.


  21. Iyer, R.P., A. Roland, Y. Jin, S. Mounir, B. Korba, J.G. Julander, and Morrey, J. D., 2004. Anti-hepatitis B virus activity of ORI-9020, a novel phosphorothioate dinucleotide, in a transgenic mouse model. Antimicrobial Agents and Chemotherapy. 48(6):2318-2320.


  22. Iyer, R.P., Y. Jin, A. Roland, Morrey, J. D., S. Mounir, and B. Korba, 2004. Phosphorothioate di- and tri-nucleotides as a novel class of anti-HBV agents. Antimicrobial Agents and Chemotherapy. 48(6):2199-2205.


  23. Morrey, J.D., C.W. Day, J.G. Julander, L.M. Blatt, D.F. Smee, and R.W. Sidwell. 2004. Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models. Antiviral Chemistry and Chemotherapy. 15:101-109.


  24. Pan, W.-H., P. Xin, Morrey, J. D., and G.A. Clawson, 2003. A self-processing ribozyme cassette: utility against human papillomavirus 11 E6/E7 mRNA and hepatitis B virus. Molecular Therapy. 9:596-606.


  25. Morrey, J.D., Transgenic HBV mouse model in the study of HBV, in Methods in Molecular Medicine: Hepatitis B and D Protocols, J. Lau and R. Hamatake, Editors, 2004. Humana Press: Totowa.


  26. Sherlock, R. and Morrey, J.D., eds. Ethical Issues in Biotechnology. 2002, Rowman & Littlefield Publishing: New York


  27. Morrissey, D.V., P.A. Lee, D.A. Johnson, S.L. Overly, J.A. McSwiggen, L. Beigelman, V.R. Mokler, L. Maloney, C. Vargeese, K. Bowman, J.T. O'Brien, C.S. Shaffer, A. Conrad, P. Schmid, Morrey, J.D., D.G. Macejak, P.A. Pavco, and L.M. Blatt, Characterization of nuclease-resistant ribozymes directed against hepatitis B virus RNA. J Viral Hepat, 2002. 9(6):411-8.


  28. Morrey, J.D., D.F. Smee, R.W. Sidwell, and C.K. Tseng, Identification of active compounds against a New York isolate of West Nile virus. Antiviral Research, 2002. 55:107-116.


  29. Julander, J.G., R.W. Sidwell, and Morrey, J.D., Characterizing antiviral activity of adefovir dipivoxil in transgenic mice expressing hepatitis B virus. Antiviral Research, 2002. 55:27-40.


  30. Julander, J.G., R.J. Colonno, R.W. Sidwell, and Morrey, J.D., Characterization of antiviral activity of entecavir in transgenic mice expressing hepatitis B virus. Antiviral Research, 2002. (accepted).


  31. Thonabulsombat, C., W.A. Reed, Morrey, J.D., K. Bates, R.A. Smart, and K.L. White, Transgenic mice carrying a gene for green fluorescent protein fused to a lytic peptide, shiva 1, under control of the bovine b-casein regulatory region. Transgenics, 2001. 3:183-197.


  32. Song, G.Y., V. Paul, H. Choo, Morrey, J.D., R.W. Sidwell, R.F. Schinazi, and C.K. Chu, Enantiomeric synthesis of D- and L-cyclopentenyl nucleosides and their antiviral activity against HIV and West Nile virus. J Med Chem, 2001. 44(23):3985-93.


  33. Sidwell, R.W., D.F. Smee, J.H. Huffman, D.L. Barnard, Morrey, J.D., K.W. Bailey, W.-C. Feng, Y.S. Babu, and K. Bush, Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWH-270201. Antiviral Research, 2001. 51:179-187.


  34. Sidwell, R.W., D.F. Smee, J.H. Huffman, D.L. Barnard, K.W. Bailey, Morrey, J.D., and Y.S. Babu, In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201. Antimicrob Agents Chemother, 2001. 45(3):749-57.


  35. Gustafson, D.R., D.J. McMahon, Morrey, J.D., and R. Nan, Appetite is not influenced by a unique milk peptide: caseinomacropeptide (CMP). Appetite, 2001. 36(2):157-63.


  36. Sherlock, R. and Morrey, J.D., Ethical issues in transgenics. Cloning, 2000. 2(3):137-144.


  37. Morrey, J.D., R.W. Sidwell, and B.A. Korba, Animal models for HBV infections - transgenic mice, in Handbook of Animal Models of Infection, O. Zak and M. Sande, Editors. 1999, Academic Press: London. p. 1009-1019.


  38. Morrey, J.D., B.E. Korba, and R.W. Sidwell, Transgenic mice as a chemotherapeutic model for hepatitis B virus infection. Antiviral Ther., 1999. 3 (Suppl 3):59-68.


  39. Morrey, J.D., K.W. Bailey, B.E. Korba, and R.W. Sidwell, Utilization of transgenic mice replicating high levels of hepatitis B virus for antiviral evaluation of lamivudine. Antiviral Research, 1999. 42:97-108.


  40. Mitalipov, S.M., K.L. White, V.R. Farrar, Morrey, J.D., and W.A. Reed, Development of nuclear transfer and parthenogenetic rabbit embryos activated with inositol 1,4,5-trisphophate. Biology of Reproduction, 1999. 60:821-827.


  41. Jackson, M.K., E.A. Mitchell, S.G. Winslow, K.M. Okleberry, R.W. Sidwell, and Morrey, J.D., Resistance to Friend leukemia virus in transgenic mice expressing the native FV-4 gene. Acta Virologica, 1999. 43:19-23.


  42. Morrey, J.D., B.E. Korba, and R.W. Sidwell, Transgenic mice as a chemotherapeutic model for HBV infection, in Therapies for Viral Hepatitis, R.F. Shinazi, J.P. Sommadossi, and H. Thomas, Editors. 1998, International Medical Press: New York. p. 161-170.


  43. Reed, W.A., P.H. Elzert, F.M. Enright, J.M. Jaynes, Morrey, J.D., and K.L. White, Interleukin 2 promoter/enhancer controlled expression of a synthetic cecropin-class lytic peptide in transgenic mice and subsequent resistance to Brucella abortus. Transgenic Research, 1997. 6:337-347.


  44. Jackson, M.K., L.G. Ellis, D.L. Barnard, and Morrey, J.D., Progression of Aleutian mink disease in natural and experimental infections. Am.J.Vet.Res., 1996. 57:1753-1758.


  45. Sidwell, R.W., R.P. Warren, K. Okleberry, R.A. Burger, and Morrey, J.D., Effect of the combination of interferon-alpha and stavudine on Friend virus infections in (B10.A X A.By)F1 mice. Journal of Infectious Diseases, 1995. 171 Suppl. 2:S93-S98.


  46. Morrey, J.D., S.M. Bourn, J.L. Morris, T.D. Bunch, and R.W. Sidwell, Activation of the human immunodeficiency virus long terminal repeat by abrasion of the skin in transgenic mice. Intervirology, 1995. 37:315-320.


  47. Bunch, T.D., K.L. White, Morrey, J.D., and F.L. Barnes, Special topics issue, Cell Biology of Embryogenesis. Theriogenology, 1995. 48:1059-1212.


  48. Sidwell, R.W., Morrey, J.D., R.P. Warren, R.A. Burger, K. Okleberry, I.S. Sim, and M. Hitchcock, Effect of the combination of human recombinant alpha interferon-A/D and 2',3'-didehydro=2',3'-dideoxythymidine on murine retrovirus disease, in Recent Advances in Chemotherapy, J. Einhorn, C.E. Nord, and S.R. Norrby, Editors. 1994, American Society for Microbiology: Washington, D.C. p. 650-651.


  49. Sidwell, R.W., Morrey, J.D., and R.P. Warren, Cytokines as potential therapies for human immunodeficiency virus infections. Canadian Journal of Infectious Diseases, 1994. 5 Suppl A:28A-35A.


  50. Marsolais, G., R. Dubuc, J. Bergeron, Morrey, J.D., E.J. Kelly, and M.K. Jackson, Importance of primer selection in the application of PCR technology to the diagnosis of bovine leukemia virus. Journal of Veterinary Diagnostic Investigation, 1994. 6:297-301.


  51. Sidwell, R.W., Morrey, J.D., K.M. Okleberry, R.A. Burger, and R.P. Warren, Immunomodulator effect on the Friend virus infection in genetically defined mice. Ann.N.Y.Acad.Sci., 1993. 685:432-446.


  52. Morrey, J.D., M.K. Jackson, T.D. Bunch, and R.W. Sidwell, Activation of the human immunodeficiency virus type 1 long terminal repeat by skin-sensitizing chemicals in transgenic mice. Intervirology, 1993. 36:65-71.


  53. Mead, J.R., Morrey, J.D., R.P. Warren, R.A. Burger, K.M. Okleberry, and R.W. Sidwell, Effect of immunomodulators in the hu-PBL-SCID mouse model. Biotechnology Therapeutics, 1993. 4:133-143.


  54. Kelly, E.J., G. Marsolais, Morrey, J.D., and M.K. Jackson, Early detection of bovine leukemia virus in experimentally infected cattle by polymerase chain reaction. Am.J.Vet.Res., 1993. 54:205-209.


  55. Ellis, L.C., M.J. Jackson, Morrey, J.D., D.L. Barnard, and Z.-Z. Li, Aleutian disease: current status and developments. Blue Book of Farming, 1993. 1:4-5.


  56. Warren, R.P., Morrey, J.D., R.A. Burger, K.M. Okleberry, and R.W. Sidwell, Murine retroviral disease enhancing effects of a pyrimidinone immunomodulator. Antiviral Res., 1992. 19:233-245.


  57. Smee, D.F., A. Pease, R.A. Burger, J.H. Huffman, Morrey, J.D., K.M. Okleberry, R.L. Noble, and R.W. Sidwell, Ganciclovir treatment of murine cytomegalovirus infection in mice immunosuppressed by prior infection with Friend leukaemia virus. Antiviral Chemistry & Chemotherapy, 1992. 3:327-333.


  58. Sidwell, R.W., K. Okleberry, R.P. Warren, R. Burger, J. Mead, and Morrey, J.D., Experiences with biological response modifiers in animal models for AIDS. Recent Adv.Chemother, 1992. 1:934-935.


  59. Sidwell, R.W., M. Hitchcock, K.M. Okleberry, R.A. Burger, R.P. Warren, and Morrey, J.D., Suppression of murine retroviral disease by 2', 3'-dideoxythymidine (D4T). Antiviral Res., 1992. 19:313-324.


  60. Morrey, J.D., J.R. Mead, R.P. Warren, K.M. Okleberry, R.A. Burger, and R.W. Sidwell, Elucidation of mode of retroviral-inhibitory effects of imexon through use of immune competent and severe combined immune deficincy (SCID) mice. Antiviral Res., 1992. 17:223-233.


  61. Morrey, J.D., S.M. Bourn, M.K. Jackson, T.D. Bunch, R.W. Sidwell, L.R. Barrows, R.A. Daynes, and C.A. Rosen, Transgenic mice as models for photo-induced gene expression: activation of human immunodeficiency virus long terminal repeat. Photochem.Photobiol., 1992. 55:87-88.


  62. Morrey, J.D., S.M. Bourn, T.D. Bunch, R.W. Sidwell, and C.A. Rosen, HIV-1 LTR activation model: evaluation of various agents in skin of transgenic mice. Journal of Acquired Immune Deficiency Syndromes, 1992. 5:1195-1203.


  63. Jackson, M.K., L.C. Ellis, Morrey, J.D., and D. Barnard, Early detection of Aleutian disease virus in mink by polymerase chain reaction. Norwegian J.Agr.Sci., 1992. 9:383-387.


  64. Morrey, J.D., K.M. Okleberry, and R.W. Sidwell, Early-initiated Zidovudine therapy prevents disease but not low levels of presistent retrovirus in mice. Journal of Acquired Immune Deficiency Syndromes, 1991. 4:506-512.


  65. Morrey, J.D., S.M. Bourn, R.W. Sidwell, D.V. Sisson, and T.D. Bunch, Two-cell blockage of FVB/N embryo development: An artifact of cell culture. Encyclia, 1991. 78:275-284.


  66. Morrey, J.D., S.M. Bourn, T.D. Bunch, R.W. Sidwell, L.R. Barrows, R.A. Daynes, and C.A. Rosen, In vivo regulation of HIV-1 long terminal repeat by UV light and various skin applicants in transgenic mice. Journal of Acquired Immune Deficiency Syndromes, 1991. 4:328-329.


  67. Morrey, J.D., S.M. Bourn, T.D. Bunch, M.K. Jackson, R.W. Sidwell, L.R. Barrows, R.A. Daynes, and C.A. Rosen, In vivo activation of human immunodeficiency virus type 1 long terminal repeat by UV light type-A (UV-A) light plus psoralen and UV-B light in skin of transgenic mice. J.Virol, 1991. 65:5045-5051.


  68. Morrey, J.D., R.P. Warren, K.M. Okleberry, R.A. Burger, M.A. Chirigos, and R.W. Sidwell, A mouse genetics model for evaluation of biological response modifiers for the treatment of retroviral infection. J.Cell.Biochem., 1990. 140:68-70.


  69. Morrey, J.D., R.P. Warren, R.A. Burger, K.M. Okleberry, R.W. Sidwell, and M.A. Chirigos, Effect of imexon on Friend virus complex in Rfv-3r/s genotype-containing mice as a model for AIDS. Ann.N.Y.Acad.Sci., 1990. 616:575-578.


  70. Morrey, J.D., R.P. Warren, R.A. Burger, K.M. Okleberry, M.A. Johnston, and R.W. Sidwell, Effects of Zidovudine on Friend virus complex infection in Rfv-3r/s genotype-containing mice used as a model for HIV infection. Journal of Acquired Immune Deficiency Syndromes, 1990. 3:500-510.


  71. Morrey, J.D., R.P. Warren, R.A. Burger, K.M. Okleberry, M.A. Chirigos, and R.W. Sidwell, Effect of imexon treatment on Friend virus complex infection in genetically defined mice as a model for HIV infection. Antiviral Res., 1990. 15:51-66.


  72. Jensen, M.M., W.C. Downs, Morrey, J.D., T.R. Nicoll, S.D. LaFevre, and C.M. Meyers, Staphylococcus of turkeys: I. Portal of entry and tissue colonization. J.Avian Dis., 1987. 31:64-69.


  73. Evans, L.H. and Morrey, J.D., Tissue-specific replication of Friend and Moloney murine leukemia viruses in infected mice. Journal of Virology, 1987. 61:1350-1357.


  74. Morrey, J.D., R.W. Sidwell, B.B. Barnett, and A.W. Mahoney, Effects of folic acid malnutrition on rotaviral infection in mice. Proceding of the Society of Experimental Biology and Medicine, 1984. 1766:77-83.